Empagliflozin in Heart Failure with a Preserved Ejection FractionStefan D. Anker, Milton Packer, Vijay Chopra et al.|New England Journal of Medicine|2021Cited by 4.6k
Dabigatran versus Warfarin in the Treatment of Acute Venous ThromboembolismSam Schulman, Samuel Z. Goldhaber, Clive Kearon et al.|New England Journal of Medicine|2009Cited by 2.6k
Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved TrialMilton Packer, Javed Butler, Faı̈ez Zannad et al.|Circulation|2021Cited by 343
Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney FunctionFaı̈ez Zannad, Milton Packer, João Pedro Ferreira et al.|Circulation|2020Cited by 276
Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fractionJaved Butler, Stefan D. Anker, Milton Packer et al.|European Heart Journal|2021Cited by 253